Clinical Trial Update: Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach [Phase 3]

View source ↗

Summary

Phase 3 clinical study of idrabiotaparinux sodium injections once-weekly for pulmonary embolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Thrombosis

Drugs mentioned

• Idrabiotaparinux sodium (idrabiotaparinux sodium)

Snippet

Sponsor: Sanofi | Conditions: Embolism, Thrombosis | Phase 3 | Status: COMPLETED